LibiGel FDA Approval Status

FDA Approved: No
Brand name: LibiGel
Generic name: testosterone
Dosage form: Gel
Company: Antares Pharma, Inc. and BioSante Pharmaceuticals Inc.
Treatment for: Hypoactive Sexual Desire Disorder

LibiGel (testosterone) is a transdermal gel formulation of testosterone in development for the treatment of hypoactive sexual desire disorder.

Development timeline for LibiGel

Date	Article
Jun 21, 2010	BioSante Pharmaceuticals Says FDA Advisory Committee Recommendation Against Flibanserin has No Impact on LibiGel
Oct 2, 2007	Antares Reports Product Progress in Growing Women's Health Portfolio

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer